Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
Collaborators
NCT03745339 · Opioid-Related Disorders, Drug Addiction
NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more
NCT04499079 · Substance-Related Disorders, Recidivism, and more
NCT05651516 · Opioid-Related Disorders
NCT03950492 · Opioid-Related Disorders
University of Colorado Health Sciences Center
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions